Oscar Health (OSCR) Falls on Downgraded Rating

We recently published a list of 10 Stocks Investors Dumped Fast. In this article, we are going to take a look at where Oscar Health, Inc.’s (NYSE:OSCR) stands against other worst-performing stocks.

Oscar Health dropped its share prices for a second day on Monday, shedding 4.28 percent to close at $14.76 following a rating downgrade from an investment firm.

On Monday, Piper Sandler lowered its price target for the company to $18 from $25 previously, but maintained its “overweight” rating on its stock. Still, the new price marked a 21.9-percent upside from its closing price on Monday.

Piper Sandler said the adjustment reflected potential policy changes from the Affordable Care Act (ACA) that could lower the number of people with health insurance, and which could significantly impact Oscar Health, Inc.’s (NYSE:OSCR) business.

According to the nonpartisan Congressional Budget Office, some 10.9 million people would lose health insurance benefits, including 1.4 million US immigrants without a legal status who are enjoying state-funded programs.

Piper Sandler said that Oscar Health, Inc.’s (NYSE:OSCR) current outlook guidance might have yet to fully reflect the risk adjustments from the policy changes.

Overall, OSCR ranks 10th on our list of worst-performing stocks. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.